Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Perineal Colostomy	NCIT_C94239
Colostomy	NCIT_C15211	[The surgical creation of an opening between the colon and the surface of the body.]
Undiluted Dose Administered	NCIT_C69280	[The amount of undiluted agent administered to a subject.]
Dose	NCIT_C25488	[A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.]
Rate of Administration	NCIT_C69281	[The speed at which an action is performed.]
Rate	NCIT_C25636	[A measurement of degree, speed, or frequency relative to time.]
Duration of Administration	NCIT_C69282	[The amount of time elapsed during the administration of an agent.]
Beat Number	NCIT_C69283	[The number of a specific beat.]
R-R Interval	NCIT_C69284	[The time measurement between the R wave of successive heartbeats as measured in milliseconds.]
ECG Measurement	NCIT_C62085	[Measurements or calculations on measurements obtained from electrocardiographic tracings.]
Frame of Reference Identity	NCIT_C69296
Acquisition Protocol	NCIT_C69297	[A protocol for creating images or image-derived measurements.]
Clinical Study Protocol	NCIT_C25320	[A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the trial, but these could be represented in other protocol referenced documents.]
Gatipotuzumab	NCIT_C94220	[A humanized monoclonal antibody recognizing the tumor-specific epitope of mucin-1 (TA-MUC1), with potential antineoplastic activity. Gatipotuzumab targets and binds to the TA-MUC1 epitopes expressed on the cell surface of tumor cells, thereby potentially activating the immune system to induce an antibody-dependent cellular cytotoxicity (ADCC) against the TA-MUC1-expressing tumor cells. TA-MUC1 is designated to MUC1 epitopes with O-glycosylated carbohydrate-induced conformational structures that are tumor-specific, thereby enabling gatipotuzumab to differentiate between tumor MUC1 and non-tumor MUC1 epitopes.]
Asian Ginseng	NCIT_C69298	[The aromatic root of perennial herbs of Panax ginseng. Ginseng, used in traditional Chinese medicine and available as a nutritional supplement, is classified as an adaptogenic herb with multiple effects, many of them are regulatory in nature. It contains a complex mixture of saponins, ginsenosides and panaxosides. Although the mechanism of action is unclear, ginseng is reported to enhance the immune system and reduce fatigue.]
Ginseng Root	NCIT_C91402	[The aromatic root of perennial herbs of Panax ginseng.]
Anti-EGFR Monoclonal Antibody GT-MAB 5.2-GEX	NCIT_C94221	[A glycoengineered form of a human monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Anti-EGFR monoclonal antibody GT-MAB 5.2-GEX specifically binds to the extracellular domain of EGFR, thereby potentially inducing an antibody-dependent cell-mediated cytotoxicity (ADCC) against EGFR-expressing tumor cells, eventually leading to tumor cell apoptosis and an inhibition of tumor cell growth. EGFR, a member of the epidermal growth factor family of extracellular protein ligands, is overexpressed on the cell surfaces of various solid tumors. This antibody has a specific glycosylation profile that may enhance its ADCC response against EGFR-expressing tumor cells.]
Anti-EGFR Monoclonal Antibody	NCIT_C133878	[Any monoclonal antibody directed against epidermal growth factor receptor (EGFR).]
Static	NCIT_C69299	[A term used to denote that something is unchanging, not dynamic.]
Technetium Tc-99m Hydroxydiphosphonate	NCIT_C94222	[A radioconjugate containing hydroxydiphosphonate (HDP) labeled with the metastable radioisotope technetium Tc (99mTc), with radioimaging activity. Upon intravenous administration, skeletal uptake of technetium Tc-99m HDP occurs as a function of skeletal blood flow and osteogenic activity. HDP has a specific affinity for hydroxyapatite crystals in bone where abnormal accumulation of increased osteoid mineralization has occurred. Labeling of HDP with 99mTc allows gamma scintigraphic imaging of areas of abnormal osteogenesis associated with malignant bone lesions.]